Back

Management of dyslipidaemias.

2 September 2019 (14:44 - 14:58)
Organised by:
Congress Presentation Part of: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD) Drug therapy Open Access ESC Congress 2019

About the speaker

Photo
Doctor Maddalena Lettino

IRCCS San Gerardo of Tintori Foundation, Monza (Italy)

4 More presentations in this session

Presentation thumbnail
What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
Professor F. Cosentino (Stockholm, SE)
Slides Video
Presentation thumbnail
New evidence from cardiovascular outcome trials.
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Benefits and risks of antithrombotic therapy in diabetes.
Professor B. Rocca (Casamassima, IT)
Slides Video
Presentation thumbnail
Glucose-lowering drugs and heart failure.
Professor P. Seferovic (Belgrade, RS)
Slides Video

Access the full session

Session thumbnail
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

The Event

Event poster

ESC Congress 2019

2 September 2019 14:44 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention